Recombinant Human ROR1/NTRKR1 Protein, N-His

Description of Recombinant Human ROR1/NTRKR1 Protein, N-His

Introduction to Recombinant Human ROR1/NTRKR1 Protein

Recombinant Human ROR1/NTRKR1 Protein, also known as Receptor tyrosine kinase-like orphan receptor 1 or neurotrophic tyrosine kinase, receptor-related 1, is a protein that plays a crucial role in cell signaling and development. It is a transmembrane protein that belongs to the receptor tyrosine kinase family and is encoded by the ROR1 gene. This protein has been extensively studied and has shown promising potential in various research and clinical applications.

Structure of Recombinant Human ROR1/NTRKR1 Protein

The recombinant form of ROR1/NTRKR1 protein is produced through genetic engineering techniques in a laboratory setting. It is a 1009 amino acid protein with a molecular weight of approximately 113 kDa. The protein consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains several cysteine-rich repeats and a Kringle domain, while the intracellular domain contains a tyrosine kinase domain.

The extracellular domain of ROR1/NTRKR1 protein is responsible for binding to its ligands, which include Wnt5a, Wnt5b, and Norrin. These ligands play a crucial role in regulating cell proliferation, migration, and differentiation. The transmembrane domain anchors the protein to the cell membrane, while the intracellular domain is responsible for initiating downstream signaling pathways.

Activity of Recombinant Human ROR1/NTRKR1 Protein

ROR1/NTRKR1 protein is primarily involved in the regulation of cell growth and development. It plays a crucial role in the Wnt signaling pathway, which is essential for embryonic development, tissue homeostasis, and stem cell maintenance. The binding of ROR1/NTRKR1 protein to its ligands activates the non-canonical Wnt signaling pathway, leading to the activation of downstream signaling molecules such as RhoA, JNK, and NF-κB.

In addition to its role in cell signaling, ROR1/NTRKR1 protein has also been implicated in various diseases. Studies have shown that this protein is overexpressed in several types of cancers, including breast cancer, lung cancer, and leukemia. It has been suggested that ROR1/NTRKR1 protein may promote tumor growth and metastasis by enhancing cell proliferation and migration. Therefore, targeting this protein may have therapeutic potential in cancer treatment.

Application of Recombinant Human ROR1/NTRKR1 Protein

The recombinant form of ROR1/NTRKR1 protein has been widely used in research and clinical applications. One of its primary applications is in the study of the Wnt signaling pathway and its role in development and disease. The availability of recombinant ROR1/NTRKR1 protein has allowed researchers to study its interactions with different ligands and its downstream signaling pathways in a controlled laboratory setting.

Furthermore, recombinant ROR1/NTRKR1 protein has also been used in the development of potential therapeutics for cancer treatment. Several studies have shown that targeting ROR1/NTRKR1 protein using monoclonal antibodies or small molecule inhibitors can inhibit tumor growth and metastasis in preclinical models. This has led to ongoing clinical trials to evaluate the efficacy of ROR1/NTRKR1 protein-targeted therapies in cancer patients.

In addition to its use in research and cancer treatment, recombinant ROR1/NTRKR1 protein has also been used as an antigen in vaccine development. Studies have shown that this protein can induce an immune response and can potentially be used as a target for immunotherapy in cancer patients.

Conclusion

Recombinant Human ROR1/NTRKR1 Protein is a crucial protein involved in cell signaling and development. Its structure, activity, and